Non-invasive antenatal diagnosis of fetal rhesus status in an alloimmunised patient

Vaidyanathan Gowri*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Alloimmunisation against the RhD red cell surface antigen was the most common cause of haemolytic disease of the fetus and newborn until recently. Maternal plasma has now almost replaced fetal cells obtained by amniocentesis or chorionic villous sampling, as the source of fetal DNA, hence eliminating the need for invasive sampling procedures. The fetal rhesus typing was done from maternal plasma in a woman in her fourth pregnancy, though she was isoimmunised in her previous pregnancies and needed invasive tests like cordocentesis in the past. The fetus was diagnosed to be rhesus negative from maternal plasma and that avoided the need for amniocentesis or cordocentesis.

Original languageEnglish
Article number1374
JournalBMJ Case Reports
Publication statusPublished - May 18 2009

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Non-invasive antenatal diagnosis of fetal rhesus status in an alloimmunised patient'. Together they form a unique fingerprint.

Cite this